Abstract

Optimal BP targets for individuals with hypertension and CKD continue to be debated. The evidence base is heavily influenced by three trials: the Modification of Diet in Renal Disease (MDRD) study, the African American Study of Kidney Disease and Hypertension (AASK), and, more recently, the Systolic

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call